Teva Pharmaceuticals

@TevaUSA ↗

Deleted No

Hibernated No

Last Checked April 3, 2023

Created

Tue Nov 08 17:49:22 +0000 2022

Likes

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

Teva Pharmaceuticals @TevaUSA

RT @cecelou18: @US_FDA One of industry’s concerns with the IRA is ensuring “the continued incentives and growth of the generic and the bios… — PolitiTweet.org

Posted Nov. 8, 2022 Retweet

Preceded By

Teva Pharmaceuticals @TevaUSA

Teva’s Cory Wohlbach is about to take the stage at #GRxBiosims to talk regulatory improvements that FDA can make to streamline biosimilar development and approval. https://t.co/ugcQZ0Li93 — PolitiTweet.org

Posted Nov. 8, 2022

Followed By

Teva Pharmaceuticals @TevaUSA

Legislation to improve therapeutic equivalence rating determination to drive access to complex generics was one of the many critical fixes left out of the UFA package, Teva’s Brian McCormick notes at #GRxBiosims https://t.co/I42TZTBhWX — PolitiTweet.org

Posted Nov. 8, 2022